ENTITY
Asymchem

Asymchem (6821 HK)

88
Analysis
Health Care • China
Asymchem Laboratories (Tianjin) Co., Ltd. is a contract development and manufacturing organization (CDMO) providing comprehensive solutions for pharmaceutical outsourcing, including small molecule, chemical macromolecule, biomacromolecule, and formulation CDMO services. The company also offers clinical research services, synthetic biology, and produces key pharmaceutical intermediates and active pharmaceutical ingredients. It was founded in 1999 and is headquartered in Tianjin, China.
more
bullish•WuXi XDC
•06 Nov 2023 21:16

WuXi XDC IPO: Valuation First-Look

WuXi XDC is pre-marketing an HKEx IPO to raise US$500m. In this note, we present our forecasts and take the first look at the potential valuation...

Logo
733 Views
Share
bullish•Midea Group Co Ltd A
•02 Nov 2023 09:48

Past A/H Listings Performance - Have Been a Mixed Bag

Two of the biggest deals in the Hong Kong pipeline are A/H listings for S.F. Holding (002352 CH) and Midea Group (000333 CH). In this note, we have...

Logo
542 Views
Share
bearish•WuXi XDC
•01 Nov 2023 18:21

WuXi XDC IPO: The Bear Case

The bear case rests on margins on a downward trend, large customer concentration, high related party transactions and volatile FCF generation.

Logo
678 Views
Share
bullish•Quantitative Analysis
•01 Nov 2023 14:13

Hong Kong Connect Flows (October): Four Months of Inflows

We analyzed the Hong Kong Connect Scheme for October and highlight flows for Meituan, Wuxi Biologics, SMIC, Great Wall Motor, HKEX.

Logo
463 Views
Share
bullish•Midea Group Co Ltd A
•01 Nov 2023 09:55

Midea A/H Listing - Filing Updates - Growth and Margins Pick Up

Midea Group Co Ltd A (000333 CH), one of the world’s largest home appliance producers, aims to raise up to US$3bn in its H-share listing.

Logo
580 Views
Share
x